Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A STOLK

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Infectious Diseases of Poverty|September 27, 2018
Burden of onchocerciasis-associated epilepsy: first estimates and research prioritiesNatalie V S Vinkeles Melchers, Sarah Mollenkopf, Robert Colebunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2019
Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025Natalie V S Vinkeles Melchers, Luc E Coffeng, Michel Boussinesq, et al.
Plos Neglected Tropical Diseases|January 16, 2016
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West AfricaSimon J O'Hanlon, Hannah C Slater, Robert A Cheke, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 30, 2021
Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategiesJoaquín M Prada, Wilma A Stolk, Emma L Davis, et al.
Frontiers in Immunology|June 16, 2020
Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell ResponsesDorian A Stolk, Aram de Haas, Jana Vree, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical ModelsWilma A Stolk, Joaquin M Prada, Morgan E Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector ControlSuzanne Verver, Martin Walker, Young Eun Kim, et al.
Parasites & Vectors|March 12, 2024
Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra LeoneIbrahim Kargbo-Labour, Mohamed S Bah, Natalie V S Vinkeles Melchers, et al.
Plos Neglected Tropical Diseases|August 10, 2019
Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communitiesNana Kwadwo Biritwum, Kwadwo K Frempong, Suzanne Verver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?Klodeta Kura, Wilma A Stolk, Maria-Gloria Basáñez, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Infectious Diseases of Poverty|September 27, 2018
Burden of onchocerciasis-associated epilepsy: first estimates and research prioritiesNatalie V S Vinkeles Melchers, Sarah Mollenkopf, Robert Colebunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2019
Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025Natalie V S Vinkeles Melchers, Luc E Coffeng, Michel Boussinesq, et al.
Plos Neglected Tropical Diseases|January 16, 2016
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West AfricaSimon J O'Hanlon, Hannah C Slater, Robert A Cheke, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 30, 2021
Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategiesJoaquín M Prada, Wilma A Stolk, Emma L Davis, et al.
Frontiers in Immunology|June 16, 2020
Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell ResponsesDorian A Stolk, Aram de Haas, Jana Vree, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical ModelsWilma A Stolk, Joaquin M Prada, Morgan E Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector ControlSuzanne Verver, Martin Walker, Young Eun Kim, et al.
Parasites & Vectors|March 12, 2024
Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra LeoneIbrahim Kargbo-Labour, Mohamed S Bah, Natalie V S Vinkeles Melchers, et al.
Plos Neglected Tropical Diseases|August 10, 2019
Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communitiesNana Kwadwo Biritwum, Kwadwo K Frempong, Suzanne Verver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?Klodeta Kura, Wilma A Stolk, Maria-Gloria Basáñez, et al.
Pageof 17